retatrutide gip glp-1 glucagon receptor agonist Calling a “GLP-3” is usually a quick sign that you don't understand the underlying biology. Retatrutide is a NuSH-based triple agonist—it targets GLP-1, GIP, and receptors. Only one of those Glucagon-like peptide-1 receptor agonists in

Heres a closer look at how hormonal imbalances can stall weight loss or cause gainand why its not your fault: Thyroid Hormones (T3 & T4): Your thyroid is your metabolisms maestro

GLP-1s (full name: glucagon-like peptide-1 receptor agonists, or GLP-1 agonists) help the pancreas release insulin, reduce blood sugar, slow the rate of stomach emptying, and increase feelings of fullness, explains Gretchen Zimmermann, RD, a registered dietitian specializing in obesity and vice president of clinical strategy at Vida Health

In December 2025, the FDA approved the first oral GLP-1 pill for weight management, and compounding pharmacies have introduced oral disintegrating tablet (ODT) formulations that bypass the digestive system entirely

2008;198(4):416 e1-426

While tirzepatide and retatrutide share the common goal of weight loss and improving metabolic health, the unique triple-hormone receptor agonism of retatrutide sets it apart, offering the potential for more significant weight loss and sustained weight reduction

Ask Your Clinician if a GLP-1 May Be Right for You GLP-1 medications have changed the landscape of care for people navigating type 2 diabetes and weight loss